Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis

被引：0

作者：

Marcellino, Bridget K. ^{[1
]}

Clementelli, Cara ^{[2
]}

Beaumont, Kristin ^{[3
]}

Schaniel, Christoph ^{[2
]}

Lu, Min ^{[4
]}

Chen, Karie ^{[2
]}

Russel, Adena ^{[2
]}

Mohammad, Ayman ^{[2
]}

Nathan, Daniel I. ^{[2
]}

Aronin, Jake ^{[2
]}

Shih, Alan H. ^{[2
]}

Sebra, Robert ^{[3
]}

Hoffman, Ronald ^{[2
,5
]}

机构：

[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA

[3] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA

[4] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, Elmhurst, NY USA

[5] MPN Res Consortium, New York, NY USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-170232

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[1] Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia
Huafeng Wang
Dandan Zhao
Le Xuan Nguyen
Herman Wu
Ling Li
Dan Dong
Estelle Troadec
Yinghui Zhu
Dinh Hoa Hoang
Anthony S. Stein
Monzr Al Malki
Ibrahim Aldoss
Allen Lin
Lucy Y. Ghoda
Tinisha McDonald
Flavia Pichiorri
Nadia Carlesso
Ya-Huei Kuo
Bin Zhang
Jie Jin
Guido Marcucci
Leukemia, 2020, 34 : 75 - 86
[2] Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia
Wang, Huafeng
Zhao, Dandan
Le Xuan Nguyen
Wu, Herman
Li, Ling
Dong, Dan
Troadec, Estelle
Zhu, Yinghui
Hoang, Dinh Hoa
Stein, Anthony S.
Al Malki, Monzr
Aldoss, Ibrahim
Lin, Allen
Ghoda, Lucy Y.
McDonald, Tinisha
Pichiorri, Flavia
Carlesso, Nadia
Kuo, Ya-Huei
Zhang, Bin
Jin, Jie
Marcucci, Guido
LEUKEMIA, 2020, 34 (01) : 75 - 86
[3] PPM1D Is a Therapeutic Target in Childhood Neural Tumors
Milosevic, Jelena
Treis, Diana
Fransson, Susanne
Gallo-Oller, Gabriel
Sveinbjoernsson, Baldur
Eissler, Nina
Tanino, Keiji
Sakaguchi, Kazuyasu
Martinsson, Tommy
Wickstroem, Malin
Kogner, Per
Johnsen, John Inge
CANCERS, 2021, 13 (23)
[4] Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-lines
Cheeseman, Matthew D.
Faisal, Amir
Rayter, Sydonia
Barbeau, Olivier R.
Kalusa, Andrew
Westlake, Maura
Burke, Rosemary
Swan, Michael
van Montfort, Rob
Linardopoulos, Spiros
Jones, Keith
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (15) : 3469 - 3474
[5] PNC-27 Targeting Plasma Membrane HDM2: A Potentially Novel Therapeutic Approach for Acute Myeloid Leukemia (AML)
Wang, Huafeng
Zhang, Bin
Zhao, Dandan
Troadec, Estelle
Meng, Weixu
Lin, Allen
Stein, Anthony S.
Al Malki, Monzr M.
Wu, Herman
Mcdonald, Tinisha
Jin, Jie
Marcucci, Guido
BLOOD, 2017, 130
[6] The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
Kojima, Kensuke
Maeda, Aya
Yoshimura, Mariko
Nishida, Yuki
Kimura, Shinya
ONCOTARGET, 2016, 7 (43) : 69625 - 69637
[7] Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation
Ogasawara, Sari
Kiyota, Yuhei
Chuman, Yoshiro
Kowata, Ayano
Yoshimura, Fumihiko
Tanino, Keiji
Kamada, Rui
Sakaguchi, Kazuyasu
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (19) : 6246 - 6249
[8] PPM1D is a prognostic marker and therapeutic target in colorectal cancer
Peng, Tian-Shu
He, Yong-Heng
Nie, Tian
Hu, Xiang-Dang
Lu, Hai-Yan
Yi, Jian
Shuai, Yun-Fei
Luo, Min
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (02) : 430 - 434
[9] Therapeutic targeting of Hdm2/HdmX E3 ligase with bioactive cyclotides
Camarero, Julio A.
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
[10] Novel truncating PPM1D mutation in a patient with intellectual disability
Porrmann, Joseph
Rump, Andreas
Hackmann, Karl
Di Donato, Nataliya
Kahlert, Anne-Karin
Wagner, Johannes
Jahn, Arne
Eger, Ines
Flury, Monika
Schrock, Evelin
Tzschach, Andreas
Gieldon, Laura
EUROPEAN JOURNAL OF MEDICAL GENETICS, 2019, 62 (01) : 70 - 72

← 1 2 3 4 5 →